Jefferies raised the firm’s price target on DocuSign (DOCU) to $115 from $95 and keeps a Buy rating on the shares. DocuSign “delivered a clean beat and raise” as both top line and billings growth accelerated, driven by early renewals, stabilization in the core and positive IAM momentum, the analyst tells investors. Despite a 60%-plus move up in the stock since fiscal Q2, the stock still “trades attractively” given its valuation discount compared to peers, the analyst added.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCU: